CIK 0001729427 · Non-accelerated filer<br>Smaller reporting company
CNS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CNSP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 822318545
- Phone
- 1-800-946-9185
- Business address
- 2100 WEST LOOP SOUTH, SUITE 900, HOUSTON, TX, 77027
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-15 | Evans Carl Anthony Director | Grant or award · Option to purchase common stock | +32,000 | 178,559 | ||
| 2021-02-05 | Downs Christopher Chief Financial Officer | Grant or award · Option to purchase common stock (right to buy) | +131,000 | 431,000 | ||
| 2021-02-05 | Climaco John M Chief Executive Officer | Grant or award · Option to purchase common stock (right to buy) | +310,000 | 749,500 | ||
| 2020-08-24 | Downs Christopher Chief Financial Officer | Purchase | +142,000 | $2.04 | $290K | 142,000 |
| 2020-06-12 | Keyes Jeffry R. Director | Grant or award · Option to purchase common stock | +46,559 | 146,559 | ||
| 2020-06-12 | Gumulka Jerzy Director | Grant or award · Option to purchase common stock | +46,559 | 146,559 | ||
| 2020-06-12 | Evans Carl Anthony Director | Grant or award · Option to purchase common stock | +46,559 | 146,559 | ||
| 2020-06-12 | Andraczke Andrzej Director | Grant or award · Option to purchase common stock | +46,559 | 146,559 | ||
| 2020-05-05 | Priebe Waldemar 10% owner | Other disposition | −1,495,867 | 7,533,133 | ||
| 2019-11-13 | Downs Christopher Chief Financial Officer | Grant or award · Option to purchase common stock (right to buy) | +300,000 | 300,000 |
Page 6 of 6 · 110 trades